Fabio Martelli
Researcher Next ID · RN-029442
Researcher · Biochemistry, Genetics and Molecular Biology
San Donato Milanese, Romania
- Works count
- 292
- Citation count
- 13,158
- H-index
- 63
- i10-index
- 140
Research interests
Publications
Regulatory RNAs in Heart Failure
Circulation · 2020 · https://doi.org/10.1161/circulationaha.119.042474
Long noncoding RNA dysregulation in ischemic heart failure
Journal of Translational Medicine · 2016 · https://doi.org/10.1186/s12967-016-0926-5
Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210
Cancer Research · 2015 · https://doi.org/10.1158/0008-5472.can-15-0405
Oxidative Stress and MicroRNAs in Vascular Diseases
International Journal of Molecular Sciences · 2013 · https://doi.org/10.3390/ijms140917319
Oxidative Stress and Epigenetic Regulation in Ageing and Age-Related Diseases
International Journal of Molecular Sciences · 2013 · https://doi.org/10.3390/ijms140917643
MicroRNA Dysregulation in Diabetic Ischemic Heart Failure Patients
Diabetes · 2012 · https://doi.org/10.2337/db11-0952
Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia
Circulation · 2011 · https://doi.org/10.1161/circulationaha.110.952325
miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition
Cell Death and Differentiation · 2011 · https://doi.org/10.1038/cdd.2011.42
miR‐210: More than a silent player in hypoxia
IUBMB Life · 2011 · https://doi.org/10.1002/iub.427
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
European Heart Journal · 2010 · https://doi.org/10.1093/eurheartj/ehq167
MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
Circulation · 2010 · https://doi.org/10.1161/circulationaha.109.928424
Microrna-221 and Microrna-222 Modulate Differentiation and Maturation of Skeletal Muscle Cells
PLoS ONE · 2009 · https://doi.org/10.1371/journal.pone.0007607
microRNA: Emerging therapeutic targets in acute ischemic diseases
Pharmacology & Therapeutics · 2009 · https://doi.org/10.1016/j.pharmthera.2009.10.003
An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210
Journal of Biological Chemistry · 2009 · https://doi.org/10.1074/jbc.m109.052779
Common micro‐RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia
The FASEB Journal · 2009 · https://doi.org/10.1096/fj.08-128579
MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3
Journal of Biological Chemistry · 2008 · https://doi.org/10.1074/jbc.m800731200
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment
Proceedings of the National Academy of Sciences · 2008 · https://doi.org/10.1073/pnas.0805514105
Hypoxia response and microRNAs: no longer two separate worlds
Journal of Cellular and Molecular Medicine · 2008 · https://doi.org/10.1111/j.1582-4934.2008.00398.x
p19ARF targets certain E2F species for degradation
Proceedings of the National Academy of Sciences · 2001 · https://doi.org/10.1073/pnas.081061398
The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway.
Genes & Development · 1996 · https://doi.org/10.1101/gad.10.23.2949
Current projects
No projects listed.